1. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
- Author
-
Verhoef LG, Lindsten K, Masucci MG, and Dantuma NP
- Subjects
- Ataxin-1, Ataxins, Biodegradation, Environmental, Drug Stability, Green Fluorescent Proteins, HeLa Cells, Humans, Luminescent Proteins chemistry, Luminescent Proteins genetics, Luminescent Proteins metabolism, Macromolecular Substances, Nerve Tissue Proteins chemistry, Nerve Tissue Proteins genetics, Nerve Tissue Proteins metabolism, Nuclear Proteins chemistry, Nuclear Proteins genetics, Nuclear Proteins metabolism, Peptides genetics, Proteasome Endopeptidase Complex, Protein Sorting Signals genetics, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Repetitive Sequences, Amino Acid, Solubility, Transfection, Ubiquitin chemistry, Ubiquitin genetics, Ubiquitin metabolism, Cysteine Endopeptidases metabolism, Multienzyme Complexes metabolism, Peptides chemistry, Peptides metabolism
- Abstract
Insoluble protein aggregates are consistently found in neurodegenerative disorders caused by expanded polyglutamine [poly(Q)] repeats. The aggregates contain various components of the ubiquitin/proteasome system, suggesting an attempt of the cell to clear the aberrant substrate. To investigate the effect of expanded poly(Q) repeats on ubiquitin/proteasome-dependent proteolysis, we targeted these proteins for proteasomal degradation by the introduction of an N-end rule degradation signal. While soluble poly(Q) proteins were degraded, they resisted proteasomal degradation once present in the aggregates. Stabilization was also observed for proteins that are co-aggregated via interaction with the expanded poly(Q) domain. Introduction of a degradation signal in ataxin-1/Q92 reduced the incidence of nuclear inclusions and the cellular toxicity, conceivably by accelerating the clearance of the soluble substrate.
- Published
- 2002
- Full Text
- View/download PDF